Found: 67
Select item for more details and to access through your institution.
PET Imaging: Update on Sarcomas.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 2, p. 249
- By:
- Publication type:
- Article
Technical Aspects of Sentinel Node Lymphoscintigraphy for Breast Cancer.
- Published in:
- Journal of Nuclear Medicine Technology, 1999, v. 27, n. 2, p. 106
- By:
- Publication type:
- Article
Data Collection Techniques for Preradioimmunotherapy Imaging.
- Published in:
- Journal of Nuclear Medicine Technology, 1995, v. 23, n. 2, p. 65
- By:
- Publication type:
- Article
NYESO-1/LAGE-1s and PRAME Are Targets for Antigen Specific T Cells in Chondrosarcoma following Treatment with 5-Aza-2-Deoxycitabine.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0032165
- By:
- Publication type:
- Article
Positron emission tomography-based assessment of metabolic gradient and other prognostic features in sarcoma.
- Published in:
- Journal of Medical Imaging, 2018, v. 5, n. 2, p. 024502-1, doi. 10.1117/1.JMI.5.2.024502
- By:
- Publication type:
- Article
Noninvasive Imaging of Experimental Lung Fibrosis.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2015, v. 53, n. 1, p. 8, doi. 10.1165/rcmb.2015-0032TR
- By:
- Publication type:
- Article
Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy.
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 2, p. 339
- By:
- Publication type:
- Article
Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography.
- Published in:
- Cancer (0008543X), 2002, v. 94, n. 12, p. 3277, doi. 10.1002/cncr.10599
- By:
- Publication type:
- Article
Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma.
- Published in:
- Cancer (0008543X), 2000, v. 89, n. 11, p. 2187, doi. 10.1002/1097-0142(20001201)89:11<2187::AID-CNCR6>3.0.CO;2-#
- By:
- Publication type:
- Article
Risk assessment in liposarcoma patients based on FDG PET imaging.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2006, v. 33, n. 11, p. 1290, doi. 10.1007/s00259-006-0170-y
- By:
- Publication type:
- Article
Assessment of the metabolic activity of bone grafts with <sup>18</sup>F-fluoride PET.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2004, v. 31, n. 9, p. 1291, doi. 10.1007/s00259-004-1568-z
- By:
- Publication type:
- Article
FDG PET imaging for grading and prediction of outcome in chondrosarcoma patients.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2004, v. 31, n. 2, p. 189, doi. 10.1007/s00259-003-1353-4
- By:
- Publication type:
- Article
Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2002, v. 29, n. 9, p. 1149, doi. 10.1007/s00259-002-0859-5
- By:
- Publication type:
- Article
Predictors of <sup>18</sup>F-DCFPyL-PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262347
- By:
- Publication type:
- Article
<sup>18</sup>F-Fluoroestradiol (<sup>18</sup>F-FES)-PET imaging in a Phase II trial of vorinostat to restore endocrine sensitivity in ER+/HER2- metastatic breast cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.244459
- By:
- Publication type:
- Article
<sup>18</sup>F-Fluoroestradiol (18F-FES)-PET imaging in a Phase II trial of vorinostat to restore endocrine sensitivity in ER+/HER2- metastatic breast cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.244459
- By:
- Publication type:
- Article
<sup>18</sup>F-Fluoroestradiol (<sup>18</sup>F-FES)-PET imaging in a Phase II trial of vorinostat to restore endocrine sensitivity in ER+/HER2- metastatic breast cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.244459
- By:
- Publication type:
- Article
<sup>18</sup>F-Fluoroestradiol (<sup>18</sup>F-FES)-PET imaging in a Phase II trial of vorinostat to restore endocrine sensitivity in ER+/HER2- metastatic breast cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.244459
- By:
- Publication type:
- Article
<sup>18</sup>F-Fluoroestradiol (<sup>18</sup>F-FES)-PET imaging in a Phase II trial of vorinostat to restore endocrine sensitivity in ER+/HER2-metastatic breast cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.120.244459
- By:
- Publication type:
- Article
<sup>18</sup>F-DCFPyL-PET/CT Imaging in Patients with Biochemical Recurrence Prostate Cancer after Primary Local Therapy.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.234799
- By:
- Publication type:
- Article
Biodistribution, Tumor Detection, and Radiation Dosimetry of <sup>18</sup>F-5-Fluoro-2'-Deoxycytidine with Tetrahydrouridine in Solid Tumors.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 4, p. 492, doi. 10.2967/jnumed.118.216994
- By:
- Publication type:
- Article
Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 7, p. 1106, doi. 10.2967/jnumed.113.130161
- By:
- Publication type:
- Article
Standards for Reporting PET Clinical Trials.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 9, p. 1516, doi. 10.2967/jnumed.113.127845
- By:
- Publication type:
- Article
Imaging in Sarcoma.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 12, p. 1903, doi. 10.2967/jnumed.111.092999
- By:
- Publication type:
- Article
Multiagent PET for Risk Characterization in Sarcoma.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 4, p. 541, doi. 10.2967/jnumed.110.083717
- By:
- Publication type:
- Article
Spatial Heterogeneity in Sarcoma <sub>18</sub>F-FDG Uptake as a Predictor of Patient Outcome.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 12, p. 1973, doi. 10.2967/jnumed.108.053397
- By:
- Publication type:
- Article
Post therapy imaging in high dose I-131 radioimmunotherapy patients.
- Published in:
- Medical Physics, 1994, v. 21, n. 7, p. 1157, doi. 10.1118/1.597343
- By:
- Publication type:
- Article
Localized beta dosimetry of 131I -labeled antibodies in follicular lymphoma.
- Published in:
- Medical Physics, 1992, v. 19, n. 1, p. 97, doi. 10.1118/1.596932
- By:
- Publication type:
- Article
Preliminary validation of the opposing view method for quantitative gamma camera imaging.
- Published in:
- Medical Physics, 1989, v. 16, n. 3, p. 382, doi. 10.1118/1.596347
- By:
- Publication type:
- Article
Radionuclide, magnetic resonance and computed tomography imaging in European round back slugs (Arionidae) and leopard slugs (Limacidae).
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-93012-2
- By:
- Publication type:
- Article
Imaging Cellular Proliferation as a Measure of Response to Therapy.
- Published in:
- Journal of Clinical Pharmacology, 2001, v. 41, n. 7S, p. 96S, doi. 10.1177/0091270001417014
- By:
- Publication type:
- Article
Imaging Cellular Proliferation as a Measure of Response to Therapy.
- Published in:
- Journal of Clinical Pharmacology, 2001, v. 41, n. 1S, p. 96s, doi. 10.1177/009127000104100114
- By:
- Publication type:
- Article
Spatially coherent modeling of 3D FDG-PET data for assessment of intratumoral heterogeneity and uptake gradients.
- Published in:
- Journal of Medical Imaging, 2022, v. 9, n. 4, p. 45003, doi. 10.1117/1.JMI.9.4.045003
- By:
- Publication type:
- Article
NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 18, p. 4564, doi. 10.1002/cncr.27446
- By:
- Publication type:
- Article
[F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults.
- Published in:
- 2009
- By:
- Publication type:
- journal article
[F-18]-Fluorodeoxy-D-Glucose—Positron Emission Tomography Response Is Associated With Outcome for Extremity Osteosarcoma in Children and Young Adults.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 15, p. 3519, doi. 10.1002/cncr.24421
- By:
- Publication type:
- Article
S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors.
- Published in:
- Oncologist, 2015, v. 20, n. 12, p. 1353, doi. 10.1634/theoncologist.2015-0295
- By:
- Publication type:
- Article
Kinetic Analysis of 2-[[sup11] C]Thymidine PET Imaging Studies of Malignant Brain Tumors: Compartmental Model Investigation and Mathematical Analysis.
- Published in:
- Molecular Imaging, 2002, v. 1, n. 3, p. 151, doi. 10.1162/153535002760235454
- By:
- Publication type:
- Article
Kinetic Analysis of 2-[[sup11] C]Thymidine PET Imaging Studies of Malignant Brain Tumors: Preliminary Patient Results.
- Published in:
- Molecular Imaging, 2002, v. 1, n. 3, p. 145, doi. 10.1162/153535002760235445
- By:
- Publication type:
- Article
Correction to: a Phase 2 Study of 16α-[18F]-Fluoro-17β-Estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC).
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase 2 study of 16α-[18F]-fluoro-17β-estradiol positron emission tomography (FES-PET) as a marker of hormone sensitivity in metastatic breast cancer (MBC).
- Published in:
- 2014
- By:
- Publication type:
- journal article
NCI-sponsored trial for the evaluation of safety and preliminary efficacy of 3'-deoxy-3'-[18F]fluorothymidine (FLT) as a marker of proliferation in patients with recurrent gliomas: preliminary efficacy studies.
- Published in:
- 2009
- By:
- Publication type:
- journal article
NCI-sponsored trial for the evaluation of safety and preliminary efficacy of FLT as a marker of proliferation in patients with recurrent gliomas: safety studies.
- Published in:
- 2008
- By:
- Publication type:
- journal article
<sup>166</sup>Ho-DOTMP Radiation-Absorbed Dose Estimation for Skeletal Targeted Radiotherapy.
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 3, p. 534
- By:
- Publication type:
- Article
Evaluation of <sup>18</sup>F-Annexin V as a PET Imaging Agent in an Animal Model of Apoptosis.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 4, p. 658
- By:
- Publication type:
- Article
Comparison of Different Quantitative Approaches to <sup>18</sup>F-Fluoride PET Scans.
- Published in:
- Journal of Nuclear Medicine, 2004, v. 45, n. 9, p. 1493
- By:
- Publication type:
- Article
PET Tracers for Osteosarcoma.
- Published in:
- Journal of Nuclear Medicine, 2004, v. 45, n. 8, p. 1424
- By:
- Publication type:
- Article
High-Dose <sup>131</sup>I-Tositumomab (Anti-CD20) Radioimmunotherapy for Non-Hodgkin's Lymphoma: Adjusting Radiation Absorbed Dose to Actual Organ Volumes.
- Published in:
- Journal of Nuclear Medicine, 2004, v. 45, n. 6, p. 1059
- By:
- Publication type:
- Article
PET Imaging of Osteosarcoma.
- Published in:
- Journal of Nuclear Medicine, 2003, v. 44, n. 6, p. 930
- By:
- Publication type:
- Article
High-Dose <sup>166</sup>Ho-DOTMP in Myeloablative Treatment of Multiple Myeloma: Pharmacokinetics, Biodistribution, and Absorbed Dose Estimation.
- Published in:
- Journal of Nuclear Medicine, 2002, v. 43, n. 10, p. 1383
- By:
- Publication type:
- Article